I am sorry to interrupt the Minister’s flow. He said that we are having the fruitful discussions that the Prime Minister wants with the industry and that they are starting to progress. However, the industry itself is starting with a figure in the single figures, nowhere near 27%. I am curious as to why we are having this discussion about progressing these regulations, as they seem to be going in totally the opposite direction from the aspirations the Prime Minister has.
Branded Health Service Medicines (Costs) (Amendment) Regulations 2023
Proceeding contribution from
Lord Warner
(Crossbench)
in the House of Lords on Thursday, 25 May 2023.
It occurred during Debates on delegated legislation on Branded Health Service Medicines (Costs) (Amendment) Regulations 2023.
Type
Proceeding contribution
Reference
830 c1031 
Session
2022-23
Chamber / Committee
House of Lords chamber
Subjects
Librarians' tools
Timestamp
2023-05-26 10:38:25 +0100
URI
http://hansard.intranet.data.parliament.uk/Lords/2023-05-25/23052555000004
In Indexing
http://indexing.parliament.uk/Content/Edit/1?uri=http://hansard.intranet.data.parliament.uk/Lords/2023-05-25/23052555000004
In Solr
https://search.parliament.uk/claw/solr/?id=http://hansard.intranet.data.parliament.uk/Lords/2023-05-25/23052555000004